{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T23:13:35Z","timestamp":1772666015079,"version":"3.50.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s99696","type":"journal-article","created":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T00:01:16Z","timestamp":1472515276000},"page":"2723-2728","source":"Crossref","is-referenced-by-count":32,"title":["Spotlight on tocilizumab and its potential in the treatment of systemic sclerosis"],"prefix":"10.2147","volume":"Volume 10","author":[{"given":"Lazaros","family":"Sakkas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,8]]},"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=32116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T23:03:21Z","timestamp":1477868601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/spotlight-on-tocilizumab-and-its-potential-in-the-treatment-of-systemi-peer-reviewed-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/dddt.s99696","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}